Aanjaneya Lifecare has locked in lower circuit of 20% at Rs 455 on BSE for second day in a row with no buyers on the counter after the pharmaceutical company said that the international investors are cautious due to wide fluctuation in the market price of scrip.
The company, which had got the government approval for raising up to Rs 405 crore through foreign currency convertible bonds (FCCB) issue, is in dialogue with international bankers for raising resources for the expansion.
“In order to achieve the growth plans of the Company, we are in dialogue with our International Bankers for raising resources for the expansion through FCCB. The international investors are cautious due to wide fluctuation in the market price of our scrip,” Aanjaneya Lifecare said in a regulatory filing.
Meanwhile, the promoters are continuously reducing their stake in the company during past one year. Total promoters holding has declined by 10.72 percentage points to 46.79% in December 2012 from 57.51% at the end of March 2012 quarter, the BSE data shows.
The stock opened at Rs 455 and has seen a combined 45,825 shares changing hands on the counter so far. There are pending sell orders for 340,415 shares on BSE and NSE.
The company, which had got the government approval for raising up to Rs 405 crore through foreign currency convertible bonds (FCCB) issue, is in dialogue with international bankers for raising resources for the expansion.
“In order to achieve the growth plans of the Company, we are in dialogue with our International Bankers for raising resources for the expansion through FCCB. The international investors are cautious due to wide fluctuation in the market price of our scrip,” Aanjaneya Lifecare said in a regulatory filing.
Meanwhile, the promoters are continuously reducing their stake in the company during past one year. Total promoters holding has declined by 10.72 percentage points to 46.79% in December 2012 from 57.51% at the end of March 2012 quarter, the BSE data shows.
The stock opened at Rs 455 and has seen a combined 45,825 shares changing hands on the counter so far. There are pending sell orders for 340,415 shares on BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%